...COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's...

Published on 20 Jan 2022 on Benzinga

...COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's...

Here's a roundup of top developments in the biotech space over the last 24 hours:

Eisai Co. Ltd. (Pink: ESALY) and Merck & Co., Inc. (NYSE: MRK) announced the publication in the New England Journal of Medicine of positive results from the Phase 3 Study 309/KEYNOTE-775 trial that evaluated the Lenvima-Keytruda combo versus chemotherapy for patients with advanced endometrial carcinoma following at least one prior platinum-based regimen in any setting.

Read the rest of the article

NASDAQ.OMER price evolution

NASDAQ.MRKR price evolution

NASDAQ.ALKS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and st...

Benzinga via Yahoo Finance 11 Jan 2024

Marker Therapeutics Inc's Uncertain Future: Understanding the Barriers to Outperformance

Long-established in the Biotechnology industry, Marker Therapeutics Inc (NASDAQ:MRKR) has enjoyed...

GuruFocus.com via Yahoo Finance 25 Aug 2023

EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System...

Plus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ: ...

Benzinga via Yahoo Finance 24 Aug 2023

Marker Therapeutics (NASDAQ:MRKR) hikes 26% this week, taking one-year gains to 95%

These days it's easy to simply buy an index fund, and your returns should (roughly) match the mar...

Simply Wall St. via Yahoo Finance 22 Jul 2023

Denali (DNLI) Provides Update on Hunter Syndrome Study

Denali Therapeutics DNLI announced positive interim results of the ongoing phase I/II study of DN...

Zacks via Yahoo Finance 1 Jul 2023

TScan Therapeutics Shares Fall After Preliminary Data Highlight In Leukemia Patients

TScan Therapeutics Inc (NASDAQ: TCRX) announced a poster presentation highlighting preliminary da...

Benzinga via Yahoo Finance 27 May 2023

Study reveals mechanism by which a circadian clock molecule leads to lung fibrosis

Abnormal sleep patterns, like those of night-shift workers, disrupt the body's natural biological...

Medical Xpress 17 Apr 2023

Merck-Moderna vaccine helps reduce chances of skin cancer

A vaccine launched by Merck and Moderna was found to reduce the chances of skin cancer when used...

The Hill 16 Apr 2023

eFFECTOR Therapeutics Collaborates With Stanford Medicine Mid-Stage Breast Cancer Study

eFFECTOR Therapeutics Inc (NASDAQ: EFTR) will collaborate with Stanford Medicine on an investigat...

Benzinga via Yahoo Finance 11 Apr 2023

Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval

The biotech sector has been in focus in the past week with key pipeline and regulatory updates. A...

Zacks via Yahoo Finance 23 Mar 2023

News

...COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's...

NASDAQ.OMER price evolution

NASDAQ.MRKR price evolution

NASDAQ.ALKS price evolution

Want to become a better investor?